Could efficacy at 1 week after galcanezumab administration for patients with migraine predict responders at 3 months? A real world study
Keisuke Suzuki, Shiho Suzuki, Tomohiko Shiina, Yasuo Haruyama, Hiroaki Fujita, Kei Funakoshi, Koichi Hirata
Topics & Concepts
MigraineNeurologyNeuroradiologyMedicineAnesthesiaPsychiatryMigraine and Headache StudiesMultiple Sclerosis Research StudiesVestibular and auditory disorders